Physical characteristics of inclusion compounds of 5-ASA in α and β cyclodextrins

被引:28
|
作者
Zerrouk, N
Dorado, JMG
Arnaud, P
Chemtob, C
机构
[1] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharm Galen Lab, F-75270 Paris, France
[2] Fac Farm & Technol, Dept Farm & Technol Farmaceut, Seville 41012, Spain
关键词
cyclodextrins; 5-amino salicylic acid; inclusions;
D O I
10.1016/S0378-5173(98)00165-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inclusions in alpha- and beta-cyclodextrins (CD) of 5-amino salicylic acid (5ASA), a light and oxygen sensitive drug, were prepared by a kneading method. The inclusions were studied in aqueous solutions and the solid state and compared to physical mixtures by several methods: differential scanning microscopy (DSC), thermomicroscopy, X-ray diffraction, scanning electron microscopy and mass spectrometry. Studies in aqueous solutions did not reveal the inclusion phenomena with alpha-CD. The stability of inclusion of 5ASA with beta-CD was very low in solution. The studies performed in solid state show that 5ASA may be included preferentially in beta-CD. Our data allow us to suggest the usefulness of a beta-CD-based dosage form to enhance the stability of 5ASA. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 50 条
  • [21] A CONTROLLED TRIAL ON THE EFFICACY AND COMPLIANCE OF 5-ASA ENEMAS VS 5-ASA SUPPOSITORIES IN DISTAL ULCERATIVE SIGMOIDITIS
    CAMPIERI, M
    LANFRANCHI, GA
    BRIGNOLA, C
    BAZZOCCHI, G
    GIONCHETTI, P
    MINGUZZI, MR
    BELLUZZI, A
    BASSO, O
    GASTROENTEROLOGY, 1986, 90 (05) : 1364 - 1364
  • [22] The History of 5-ASA Compounds and their Use in Ulcerative Colitis - Trailblazing Discoveries in Gastroenterology
    Mayberry, John
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2013, 22 (04) : 375 - 377
  • [23] INCLUSION COMPOUNDS OF CYCLODEXTRINS
    CRAMER, F
    HETTLER, H
    NATURWISSENSCHAFTEN, 1967, 54 (24) : 625 - &
  • [24] Cyclodextrins inclusion compounds
    Luca, Constantin
    Grigoriu, Ana-Maria
    REVISTA DE CHIMIE, 2006, 57 (03): : 248 - 252
  • [25] TOPICAL SALICYLATE THERAPY (4-ASA AND 5-ASA ENEMAS)
    GINSBERG, AL
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1989, 18 (01) : 35 - 42
  • [26] 5-ASA nach wie vor Standard
    Thomas Meißner
    MMW - Fortschritte der Medizin, 2019, 161 (1) : 73 - 73
  • [27] TREATMENT OF CROHNS-DISEASE WITH 5-ASA
    KATZ, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (09): : 1315 - 1317
  • [28] 5-Asa Treatment In Chronic Beryllium Disease
    Maier, L. A.
    Barkes, B.
    Gillespie, M.
    Elliott, J.
    Mondello, G.
    Huang, J.
    Day, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] Experience of 5-ASA nephrotoxicity in the United Kingdom
    Jayaprakash, A
    Stevens, PE
    Mian, S
    McIntyre, AS
    Logan, RF
    Muller, AF
    GUT, 2002, 50 : A45 - A45
  • [30] Treatment failure with 5-ASA in patients with IBD
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (05): : 405 - 405